Key Points
Question
What is the association of the use of checkpoint inhibitors with the risk of neurological adverse events?
Findings
In this meta-analysis of 39 trials evaluating the use of checkpoint inhibitors to treat various malignant neoplasms, the risk of neurological adverse events was lower when compared with chemotherapy. However, the risk of neurologic adverse events was higher with checkpoint inhibitors compared with placebo.
Meaning
These results suggest patients treated with checkpoint inhibitors are less likely to develop neurologic adverse events compared with other cancer medications, particularly cytotoxic chemotherapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.